YUEXIU TRANSPORT (01052): "24 Yuexiu Transport MTN002" will pay interest on June 27th.
Yuexiu Transportation Infrastructure (01052) announces that Yuexiu Transportation Infrastructure Co., Ltd.'s 2024 second medium-term notes (bond abbreviation: 24 Yuexiu Transportation MTN002, bond code: 102482759.IB) will pay interest on June 27, 2026. The total issuance amount of this bond is 500 million yuan, with a coupon rate of 2.16% for this interest period.
YUEXIUTRANSPORT (01052) announces that YUEXIUTRANSPORT Limited Company's 2024 second tranche medium-term notes (bond abbreviation: 24 Yuexiu Transport MTN002, bond code: 102482759.IB) will pay interest on June 27, 2026. The total issuance amount of this bond is RMB 500 million, and the coupon rate for this interest period is 2.16%.
Related Articles

HK Stock Market Move | Inland insurance stocks collectively rebounded. The Shanghai Lujiazui Finance & Trade Zone Development forum released multiple significant signals. Institutions are optimistic about the repair brought by high growth in the second quarter performance.

HK Stock Market Move | LIULIUMEI(06658) rose more than 19% to reach a new all-time high since its market debut, with an increase of over 270% compared to its IPO price.

HK Stock Market Move | INSILICO (03696) rose nearly 8% in the afternoon, reaching a cooperation agreement with SK Biopharmaceuticals in the field of AI-driven research and development in neuroimmunology diseases.
HK Stock Market Move | Inland insurance stocks collectively rebounded. The Shanghai Lujiazui Finance & Trade Zone Development forum released multiple significant signals. Institutions are optimistic about the repair brought by high growth in the second quarter performance.

HK Stock Market Move | LIULIUMEI(06658) rose more than 19% to reach a new all-time high since its market debut, with an increase of over 270% compared to its IPO price.

HK Stock Market Move | INSILICO (03696) rose nearly 8% in the afternoon, reaching a cooperation agreement with SK Biopharmaceuticals in the field of AI-driven research and development in neuroimmunology diseases.

RECOMMEND





